In addition, the combination of TMC8 with FRMD5, PCMT1, PDGFA, YIPF4, or ZNF324B has been proposed as a novel prognostic biomarker of HNSCC to guide the clinical treatment [48]. Here, PCMT1 is linked to head and neck squamous cell carcinoma.